       Document 0713
 DOCN  M9640713
 TI    Human T-cell leukemia virus type II infection among high risk groups and
       its influence on HIV-1 disease progression.
 DT    9604
 AU    Giacomo M; Franco EG; Claudio C; Carlo C; Anna DA; Anna D; Franco F;
       Cattedra di Malattie Infettive, Universita degli Studi di Parma,; Italy.
 SO    Eur J Epidemiol. 1995 Oct;11(5):527-33. Unique Identifier : AIDSLINE
       MED/96139646
 AB    The prevalence and the risk factors of the human T-cell leukemia virus
       type I/II (HTLV-I/II) infection were evaluated among 552 individuals at
       high risk for HIV-1. HTLV infections showed a low (1.6%) prevalence,
       were restricted to intravenous drug addicts and were due to HTLV-II
       alone. Moreover, in order to weigh the influence of HTLV-II on the
       natural history of HIV-1 infection, the clinical outcome of HIV-1
       disease was compared between subjects with and without HTLV-II
       coinfection. Our findings showed that HTLV-II does not adversely affect
       the outcome of HIV-1 infection. Infact, a slower disease progression has
       been recorded in some HTLV-II coinfected subjects.
 DE    Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/PHYSIOPATHOLOGY  Adult
       Comorbidity  Comparative Study  Disease Progression  DNA, Viral/ANALYSIS
       Female  Homosexuality/STATISTICS & NUMER DATA  Human  HIV
       Antibodies/BLOOD  HIV Infections/*EPIDEMIOLOGY/PHYSIOPATHOLOGY
       *HIV-1/GENETICS/IMMUNOLOGY  HTLV-BLV Antibodies/BLOOD
       HTLV-II/GENETICS/IMMUNOLOGY  HTLV-II
       Infections/*EPIDEMIOLOGY/PHYSIOPATHOLOGY  Italy/EPIDEMIOLOGY  Male
       Prevalence  Prospective Studies  Risk Factors  Substance Abuse,
       Intravenous/EPIDEMIOLOGY  Survival Rate  T-Lymphocyte Subsets/PATHOLOGY
       JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

